Dr. Narendran, Director, Indian Medicine (Siddha) Faculty, has been requested by the Head of the College's Pharmacology Department to ensure intellectual protection for, and commercialisation of, a conceptualization that he had developed for coronary atherosclerosis.
Such a request was made for the first time in the College, as well as the Director has to conclude how it fits into the educational and research mandate of the School. He also has with him a uncomplicated marketplace study of the possibility of the formulation.
PUBLICATION DATE: May 27, 2011 PRODUCT #: A00010-PDF-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
University of Virginia Investment Management Company (UVIMCO)-2007
Framework for Analyzing Environmental Voluntary Agreements
Circon (A)
Knowledge Management at Andersen Consulting
Willamette Industries: No Pay at Risk Compensation
Vancouver City Savings Credit Union: Working Dads (A)
Performance Management
How Useful is the Theory of Disruptive Innovation?
The Sandbox: Creating a Bottom-Up Entrepreneurial Ecosystem
Retail Execution: Linens ‘N Things
